MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4103/0973-1482.180680

Медицинская библиотека · Journal of cancer research and therapeutics · 2018

Treatment of breast cancer in a patient of Alport syndrome-induced chronic renal failure: A triumph story.

Modi Gaurang, Madabhavi Irappa, Patel Apurva, Anand Asha

Клинический случайПисьмо в редакциюПеревод в очереди

Аннотация

Alport syndrome is a hereditary disease of the glomerular basement membrane, characterized by the familial occurrence of progressive, hematuric nephropathy with sensorineural deafness. We are reporting here a young adult female, suffering from Alport syndrome with significant family history and on maintenance twice-weekly hemodialysis (HD), had been diagnosed with triple negative earlystage right-sided breast cancer. The patient was managed successfully with surgery and adjuvant chemotherapy with 3 cycles of 5-flurouracil, doxorubicin, and cyclophosphamide and 3 cycles of docetaxel. In this case, our clinical challenge was dose reduction of chemotherapeutic agents according to creatinine clearance and timing of HD in each cycle of chemotherapy. We confronted this by dose reduction of cyclophosphamide and timing of chemotherapy was at least 12 h after HD for each and every cycle. Patient is in regular follow-up in our department since 20 months without any recurrence of the disease.

Для цитирования: Modi Gaurang, Madabhavi Irappa, Patel Apurva, Anand Asha. Treatment of breast cancer in a patient of Alport syndrome-induced chronic renal failure: A triumph story.. Journal of cancer research and therapeutics. 2018. DOI: 10.4103/0973-1482.180680.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.